Chicago, Illinois: Higher levels of both white matter hyperintensity (WMH) and indices of cerebrovascular disease pathologies are associated with more progressive parkinsonism in older adults, shows a recently released research. The study was published in the journal JAMA Neurology on November 1, 2021.
Progressive parkinsonism is a common occurrence in older adults without a diagnosis of Parkinson's disease. It is associated with adverse health outcomes but its pathologic basis is controversial. Shahram Oveisgharan, Rush University Medical Center, Chicago, Illinois, and colleagues, therefore, aimed to examine if the burden of cerebral white matter hyperintensity, a common manifestation of cerebrovascular disease pathologies, is associated with the rate of progressive parkinsonism in a community-based cohort study.
The study included participants recruited in 3 ongoing cohorts that began enrollment in 1994, 1997, and 2004. Participants were observed for a mean of 7.5 years, prior to death. From 4427 participants enrolled in the 3 cohorts, 2134 died. Postmortem autopsy was performed in 1725 decedents, and 598 also had ex vivo brain magnetic resonance imaging (MRI).
Participants were excluded if they were missing any of the 9 postmortem pathology indices (n = 22) or repeated parkinsonism assessment (n = 41) or had received a clinical diagnosis of Parkinson disease at any point before or during the study (n = 19) and were analyzed from April 2020 to August 2021.
Parkinsonism was assessed annually using 26 items of a modified motor portion of the Unified Parkinson's Disease Rating Scale. A summary score was developed from the item scores, with higher scores indicating more severe parkinsonism.
Of 516 included decedents, 364 (70.5%) were female, and the mean age at death was 90.2 years.
Following were the findings from the study:
- Higher WMH was associated with faster progressive parkinsonism (estimate, 0.024; SE, 0.008).
- The attenuation of this association was greater when controlling for indices of cerebrovascular disease pathologies than when controlling for neurodegenerative pathologies (cerebrovascular disease: estimate, 0.019; SE, 0.008; neurodegenerative: estimate, 0.022; SE, 0.008), but both remained significant.
"Further studies are needed to determine if in vivo brain imaging of older adults for evidence of WMH and aggressive medical treatment of vascular risk factors and diseases can reduce the occurrence or severity of late-life parkinsonism," wrote the authors.
Reference:
Oveisgharan S, Yu L, Poole VN, et al. Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging. JAMA Neurol. Published online November 01, 2021. doi:10.1001/jamaneurol.2021.3996
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.